表紙
市場調查報告書

EPA和DHA的全球市場:各類型,濃度,不同形狀,各原料,各用途,各地區 - 成長,趨勢,預測

EPA & DHA Market - Growth, Trends, and Forecasts (2020-2025)

出版商 Mordor Intelligence LLP 商品編碼 754911
出版日期 內容資訊 英文 100 Pages
商品交期: 2-3個工作天內
價格
Back to Top
EPA和DHA的全球市場:各類型,濃度,不同形狀,各原料,各用途,各地區 - 成長,趨勢,預測 EPA & DHA Market - Growth, Trends, and Forecasts (2020-2025)
出版日期: 2020年02月01日內容資訊: 英文 100 Pages
簡介

本報告提供全球EPA和DHA市場相關調查分析,彙整市場概要,市場動態,各類型,濃度,不同形狀,各原料,各用途,各地區分析,競爭情形,主要企業的簡介等相關資訊。

第1章 簡介

第2章 市場考察

  • 市場概要
  • 市場趨勢

第3章 市場動態

  • 促進要素
  • 抑制因素
  • 市場魅力:波特的五力分析

第4章 市場區隔

  • 各類型
    • EPA
    • DHA
  • 各濃度
    • 高濃度
    • 中濃度
    • 低濃度
  • 不同形狀(脂肪酸)
    • 三酸甘油酯
    • 乙酯
  • 各原料
    • 魚油
    • 藻類油
    • 磷蝦油
    • 其他
  • 各用途
    • 嬰幼兒用牛奶
    • 補充品
    • 強化食品/飲料
    • 醫藥品
    • 其他

第5章 EPA和DHA:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東/非洲

第6章 EPA和DHA市場競爭情形

  • 主要企業
  • 市場佔有率分析
  • 主要企業的策略

第7章 企業簡介

  • Royal DSM
  • Croda International Plc
  • Omega Protein Corporation
  • Archer Daniels Midland Company
  • Corbion
  • BASF SE
  • Pelagia AS
  • Golden Omega S.A.
  • Arctic Nutrition AS
  • Organic Technologies
  • KD Pharma Group
  • Novotech Nutraceuticals Inc.
  • Novasep Holding SAS

第8章 免責聲明

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 65559

Global EPA & DHA market is projected to grow at the CAGR of 9.7% during the forecast period (2020 - 2025).

  • Globally, EPA and DHA are gaining importance and becoming a part of the consumer's daily diet. The key reasons for this change have been the increased prevalence of lifestyle diseases and people taking preventive healthcare measures. Moreover, emerging applications of EPA and DHA in food, dietary supplements, and clinical nutrition are further stimulating market growth.
  • On the basis of type, the market is categorized into eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
  • In terms of application, dietary supplement is the largest shareholding category of the market followed by infant nutrition and pharmaceutical, due to developments in Asia-Pacific, Eastern Europe, and Latin American market.
  • The market is budding, owing to growing information about the advantages of consuming supplements and functional food enriched with omega-3 fatty acids, among consumers.
  • Being a rich source of EPA and DHA and ease of extraction, fish oil is the major source for these ingredients.

Key Market Trends

High Concentrate EPA & DHA Dominated the Market by Concentrate Type

The range of high concentration of omega-3 fatty acids (EPA, DHA) varies from 700-900 mg/g. The high concentrated forms of EPA and DHA are preferred in the pharmaceutical sector for their product formulations. The increasing popularity of omega-3 supplements, especially in the developing markets of Asia-Pacific, Middle East, and Latin America has prompted manufacturers to demand highly concentrated versions of EPA and DHA, owing to their ease of processing and purity parameters. The purity concerns, desire for high effectiveness and bioavailability has also led infant formulae manufacturers to seek for high concentrated forms of EPA and DHA. The other advantage of highly concentrated forms of EPA and DHA is that it reduces the dosage requirements in order to produce desirable results. The supercritical fluid chromatography method is generally used for high concentration omega-3 products as it produces a maximum concentration of up to 99%. SFC enables the industrial production of up to 99% pure fatty acids such as EPA 99%, DHA 99%. The high concentrated forms of EPA and DHA is expected to embark on premiumization aspect of consumer's purchasing behavior.

China Dominated the EPA & DHA Market in Asia-Pacific Region

The strong manufacturing base, increasing middle-class population, disposable income, and health awareness are fueling the consumption of EPA and DHA ingredients in China. The high birth rate and the recent abolition of the one-child policy in China are expected to fuel the demands for DHA-based ingredients for infant nutritional formulae. Infant formulae followed by dietary supplements are two major application areas in the Chinese EPA and DHA market. The dietary supplements sector in China marketplace is expected to emerge as a lucrative application sector for EPA and DHA ingredients amid an increase in discretionary spending.

Competitive Landscape

During the last few years, various global companies have become active in the global EPA and DHA market with tactical acquisitions, mergers, and partnership. For instance: Veramaris (established 50:50 joint venture between DSM & Evonik in 2017) will be producing omega-3 fatty acids (containing rich amount of EPA and DHA) derived from natural marine algae for animal nutrition. Companies, like ADM, BASF SE, Organic technologies, and Novotech Nutraceuticals came up with new products launches. For example, Organic Technologies' launch of two new DHA omega-3 concentrates within its existing product line i.e. a high DHA concentrate and a medium strength DHA (non-tuna) tuna oil alternative.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Drivers
  • 4.2 Market Restraints
  • 4.3 Porter's Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Bargaining Power of Buyers/Consumers
    • 4.3.3 Bargaining Power of Suppliers
    • 4.3.4 Threat of Substitute Products
    • 4.3.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Eicosapentaenoic Acid (EPA)
    • 5.1.2 Docosahexaenoic Acid (DHA)
  • 5.2 By Concentration Type
    • 5.2.1 High Concentrated
    • 5.2.2 Medium Concentrated
    • 5.2.3 Low Concentrated
  • 5.3 By Form
    • 5.3.1 Triglycerides
    • 5.3.2 Ethyl Esters
  • 5.4 By Source
    • 5.4.1 Fish Oil
    • 5.4.2 Algae Oil
    • 5.4.3 Krill Oil
    • 5.4.4 Other Sources
  • 5.5 By Application
    • 5.5.1 Infant Formulae
    • 5.5.2 Dietary Supplements
    • 5.5.3 Fortified Food and Beverages
    • 5.5.4 Pharmaceuticals
    • 5.5.5 Other Applications
  • 5.6 Geography
    • 5.6.1 North America
      • 5.6.1.1 United States
      • 5.6.1.2 Canada
      • 5.6.1.3 Mexico
      • 5.6.1.4 Rest of North America
    • 5.6.2 Europe
      • 5.6.2.1 Spain
      • 5.6.2.2 United Kingdom
      • 5.6.2.3 France
      • 5.6.2.4 Germany
      • 5.6.2.5 Italy
      • 5.6.2.6 Rest of Europe
    • 5.6.3 Asia-Pacific
      • 5.6.3.1 China
      • 5.6.3.2 Japan
      • 5.6.3.3 India
      • 5.6.3.4 Singapore
      • 5.6.3.5 Australia
      • 5.6.3.6 Rest of Asia-Pacific
    • 5.6.4 South America
      • 5.6.4.1 Brazil
      • 5.6.4.2 Argentina
      • 5.6.4.3 Rest of South America
    • 5.6.5 Middle East and Africa
      • 5.6.5.1 South Africa
      • 5.6.5.2 United Arab Emirates
      • 5.6.5.3 Rest of Middle East & Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Market Share Analysis
  • 6.2 Strategies Adopted by Players
  • 6.3 Most Active Companies
  • 6.4 Company Profiles
    • 6.4.1 Koninklijke DSM N.V
    • 6.4.2 KD Pharma Group
    • 6.4.3 Archer Daniels Midland Company
    • 6.4.4 Corbion N.V.
    • 6.4.5 Novasep Holding SAS
    • 6.4.6 Neptune Wellness Solutions
    • 6.4.7 BASF SE
    • 6.4.8 Clover Corporation Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top